• 1
    Krieg, A. M., Hartmann, G. and Yi, A. K., Mechanism of action of CpG DNA. Curr. Top.Microbiol. Immunol. 2000. 247: 121.
  • 2
    Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A. and Klinman, D. M., CpG motifs in bacterial DNA trigger direct B cell activation. Nature 1995. 374: 546549.
  • 3
    Weeratna, R. D., McCluskie, M. J., Xu, Y. and Davis, H. L., CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 2000. 18: 17551762.
  • 4
    Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V. and Harding, C. V., CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 1997. 186: 16231631.
  • 5
    Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M. D., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A. and Raz, E., Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 1997. 3: 849854.
  • 6
    Krieg, A. M. and Wagner, H., Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA. Immunol. Today 2000. 21: 521526.
  • 7
    Hartmann, G. and Krieg, A. M., Mechanism and function of a newly identified CpG DNA motif in human primary cells. J. Immunol. 2000. 164: 944952.
  • 8
    Hartmann, G., Weeratna, R. D., Ballas, Z. K., Payette, P., Blackwell, S., Suparto, I., Rasmussen, W. L., Waldschmidt, M., Sajuthi, D., Purcell, R. H., Davis, H. L. and Krieg, A. M., Delineation of a CpG phosphorothioate oligodeoxynucleotidefor activating primate immune responses in vitro and in vivo. J. Immunol. 2000. 164: 16171624.
  • 9
    Davis, H. L., Suparto, II, Weeratna, R. R., Jumintarto, Iskandriati, D. D., Chamzah, S. S., Maruf, A. A., Nente, C. C., Pawitri, D. D., Krieg, A. M., Heriyanto, Smits, W. and Sajuthi, D. D., CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans. Vaccine 2000. 18: 19201924.
  • 10
    Hartmann, G. and Krieg, A. M., CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene Ther. 1999. 6: 893903.
  • 11
    Hartmann, G., Krug, A., Waller-Fontaine, K. and Endres, S., Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin. Mol. Med. 1996. 2: 429438.
  • 12
    Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque,S., Liu, Y. J., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767811.
  • 13
    Hartmann, G., Weiner, G. and Krieg, A. M., CpG DNA: a potent signal for growth, activation and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 1999. 96: 93059310.
  • 14
    Grouard, G., Rissoan, M. C., Filgueira, L., Durand, I., Banchereau, J. and Liu, Y. J., The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 1997. 185: 11011111.
  • 15
    Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A. and Colonna, M., Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 1999. 5: 919923.
  • 16
    Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S. and Liu, Y. J., The nature of the principal type 1 interferon-producing cells in human blood. Science 1999. 284: 18351837.
  • 17
    Rissoan, M. C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., de Waal Malefyt, R. and Liu, Y. J., Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999. 283: 11831186.
  • 18
    Kadowaki, N., Antonenko, S., Lau, J. Y. and Liu, Y. J., Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 2000. 192: 219226.
  • 19
    Cella, M., Facchetti, F., Lanzavecchia, A. and Colonna, M., Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 2000. 1: 305310.
  • 20
    Aderem, A. and Ulevitch, R. J., Toll-like receptors in the induction of the innate immune response. Nature 2000. 406: 782787.
  • 21
    Chuang, T. H. and Ulevitch, R. J., Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 2000. 11: 372378.
  • 22
    Chuang, T. and Ulevitch, R. J., Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta. 2001. 1518: 157161.
  • 23
    Du, X., Poltorak, A., Wei, Y. and Beutler, B., Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Netw. 2000. 11: 362371.
  • 24
    Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B. and Beutler, B., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998. 282: 20852088.
  • 25
    Visintin, A., Mazzoni, A., Spitzer, J. H., Wyllie, D. H., Dower, S. K. and Segal, D. M., Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 2001. 166: 249255.
  • 26
    Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K. and Akira, S., A Toll-like receptor recognizes bacterial DNA. Nature 2000. 408: 740745.
  • 27
    Muzio, M., Bosisio, D., Polentarutti, N., D'Amico, G., Stoppacciaro, A., Mancinelli, R., van′t Veer, C., Penton-Rol, G., Ruco, L. P., Allavena, P. and Mantovani, A., Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 2000. 164: 59986004.
  • 28
    Biron, C. A., Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin. Immunol. 1998. 10: 383390.
  • 29
    Kaukoranta-Tolvanen, S. S., Teppo, A. M., Laitinen, K., Saikku, P., Linnavuori, K. and Leinonen, M., Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb. Pathog. 1996. 21: 215221.
  • 30
    Lanzavecchia, A., Licence to kill. Nature 1998. 393: 413414.
  • 31
    Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996. 184: 747752.
  • 32
    Schulz, O., Edwards, D. A., Schito, M., Aliberti, J., Manickasingham, S., Sher, A. and Reis e Sousa, C., CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000. 13: 453462.
  • 33
    Gallucci, S., Lolkema, M. and Matzinger, P., Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 1999. 5: 12491255.
  • 34
    Cousens, L. P., Peterson, R., Hsu, S., Dorner, A., Altman, J. D., Ahmed, R. and Biron, C. A., Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J. Exp. Med. 1999. 189: 13151328.
  • 35
    Krug, A., Rothenfusser, S., Hornung, V., Jahrsdörfer, B., Ballas, Z., Endres, S., Krieg, A. M. and Hartmann, G., Identification of CpG oligonucleotide sequences with high induction of IFN-α/-β in plasmacytoid dendritic cells. Eur. J. Immunol. 2001. 31: 21542163.
  • 36
    Bauer, M., Redecke, V., Ellwart, J. W., Scherer, B., Kremer,J. P., Wagner, H. and Lipford, G. B., Bacterial CpG DNA triggers activation and maturation of human CD11c, CD123+ dendritic cells. J. Immunol. 2001. 166: 5000 – 5007.
  • 37
    Kadowaki, N., Antonenko, S. and Liu, Y. J., Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN. J. Immunol. 2001.166: 2291 – 2295.
  • 38
    Belardelli, F., Ferrantini, M., Santini, S. M., Baccarini, S., Proietti, E., Colombo, M. P., Sprent, J. and Tough, D. F., The induction of in vivo proliferation of long-lived CD44hi CD8+ T cells after the injection of tumor cells expressing IFN-alpha1 into syngeneic mice. Cancer Res. 1998. 58: 57955802.
  • 39
    Tough, D. F., Borrow, P. and Sprent, J., Induction of bystander T cell proliferation by virusesand type I interferon in vivo. Science 1996. 272: 19471950.
  • 40
    Zhang, X., Sun, S., Hwang, I., Tough, D. F. and Sprent, J., Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 1998. 8: 591599.
  • 41
    Mangi, M. H. and Newland, A. C., Interleukin-3 in hematology and oncology: current state of knowledge and future directions. Cytokines Cell. Mol. Ther. 1999. 5: 8795.
  • 42
    Guba, S. C., Stella, G., Turka, L. A., June, C. H., Thompson, C. B. and Emerson, S. G., Regulation of interleukin 3 gene induction in normal human T cells. J. Clin. Invest. 1989. 84: 17011706.
  • 43
    Loetscher, M., Loetscher, P., Brass, N., Meese, E. and Moser, B., Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur. J. Immunol. 1998. 28: 36963705.
  • 44
    Sallusto, F. and Lanzavecchia, A., Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 2000. 177: 134140.
  • 45
    Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708712.
  • 46
    Hartmann, G., Krug, A., Eigler, A., Moeller, J., Murphy, J., Albrecht, R. and Endres, S., Specific suppression of human tumor necrosis factor-alpha synthesis by antisense oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev. 1996. 6: 291299.
  • 47
    Hartmann, G., Krug, A., Bidlingmaier, M., Hacker, U., Eigler, A., Albrecht, R., Strasburger, C. J. and Endres, S., Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes. J. Pharmacol. Exp. Ther. 1998. 285: 920928.
  • 48
    Bals, R., Lang, C., Weiner, D. J., Vogelmeier, C., Welsch, U. and Wilson, J. M., Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules. Clin. Diagn. Lab. Immunol. 2001. 8: 370375.